The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.1 - Manufacture of basic pharmaceutical products
300 jobs Number of planned job creations
Announcement Date
12 November 2013
Employment effect (start)
Foreseen end date
31 December 2018
Description
German biotechnology company Biotest announced to create at least 300 jobs in Dreieich (Hesse) by extending its production capacities until 2018. This is part of the company’s “Biotest Next Level” investment programme.
Currently, Biotest employs 1,940 people worldwide, 850 of them in Dreieich, where the investment programme shall redouble production capacities.
Sources
12 November 2013: Biotest (press release)
14 November 2013: Offenbacher Post
Citation
Eurofound (2013), Biotest, Business expansion in Germany, factsheet number 76197, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/76197.